The UK competition watchdog the Office for Fair Trading has fined Reckitt Benckiser £10.2 million ($16 million) after the company admitted abusing its dominant position when supplying heartburn medicines to the National Health Service
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Rebecca Newman at Addleshaw Goddard, who live-reported on the seminal dispute, unpicks the trials and tribulations of the case and considers its impact
IP leaders at Brandsmiths and Bird & Bird, who were on opposing sides at the UK Supreme Court in Iconix v Dream Pairs, unpick the landmark case and its ramifications